Mitral valve re-replacement for impaired bioprosthesis after 19 years in a patient undergoing steroid treatment

Journal of Heart Valve Disease

Volumn 12, Issue 1, 2003, Pages 45-47

  Shimazaki, Yasuhisa ^a   Kuraoka, Setsuo ^a   Takeda, Fumihiro ^a   Watanabe, Takao ^a   Inui, Kiyoshige ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; STEROID;

ADULT; ANNULOPLASTY; ARTICLE; CALCIFICATION; CASE REPORT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; HANCOCK VALVE PROSTHESIS; HEART VALVE BIOPROSTHESIS; HEPATOMEGALY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERM CARE; MALE; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; OSTEOPOROSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAINT JUDE HEART VALVE PROSTHESIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; STEROID THERAPY; TRICUSPID VALVE; TRICUSPID VALVE REGURGITATION; VIRUS INFECTION; X RAY ANALYSIS;

ADRENAL CORTEX HORMONES; BIOPROSTHESIS; COMORBIDITY; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PARAPARESIS, TROPICAL SPASTIC; REOPERATION; TIME FACTORS;

EID: 0037266921     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ferrans VJ, Boyce SW, Billingham ME, Jones M, Ishihata T, Roberts WC. Cardiac deposits in porcine bioprostheses: Structure and pathogenesis. Am J Cardiol 1980;46:721-734
2. Shoen FJ, Kujovich JL, Levy RJ, Sutton MSJ. Bioprosthetic valve failure. In: Waller BF (ed.). Contemporary issues in cardiovascular pathology. F.A. Davis Co.: Philadelphia, 1988:289-317
3. Thubrikar MJ, Deck JD, Aouad J, Nolan SP. Role of mechanical stress in calcification of aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1983;86:115-125
4. Grabenwoger M, Grimm M, Eybl E, et al. New aspects of the degeneration of bioprosthetic heart valves after long-term implantation. J Thorac Cardiovasc Surg 1992;104:14-21
5. Zavazava N, Simon A, Sievers HH, Bernhard A, Muller-Ruchhiltz W. Porcine valves are re-endothelialized by human recipient endothelium in vivo. J Thorac Cardiovasc Surg 1995;109:702-706
6. Cohn LH, Collins JJ, Rizzo RJ, Adams DH, Couper GS, Aranki SF. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg 1998;66:S30-S34
7. Bernal JM, Rabasa JM, Cagigas JC, Echevarria JR, Carrion MF, Revuelta JM. Valve-related complications with the Hancock 1 porcine bioprosthesis. J Thorac Cardiovasc Surg 1991;101:871-880
8. Eishi K, Ishibashi-Ueda H, Nakano K, Kosakai Y, Sasako Y, Kobayahi J, Yutani C. Calcific degeneration of bioprosthetic aortic valves in patients with receiving steroid therapy. J Heart Valve Dis 1996;5:668-672
9. Masuda H, Moriyama Y, Toda R, et al. The influence of human T lymphotropic virus type 1 infection on the outcome of cardiovascular surgery. J Thorac Cardiovasc Surg 2000; 120:699-706
10. Bernal C, Bernal E, Patarca R, et al. Altered cell-mediated immunity in asymptomatic Colombian natives with positive or indeterminate serology for HYLV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:121-123
11. Hisatomi K, Isomura T, Kawara T, Aoyagi S. Changes in lymphocyte subsets, mitogen responsiveness and interleukin-2 production after cardiac operations. J Thorac Cardiovasc Surg 1989;98:580-591